Global /Sweden /Healthcare /Medical Devices /SPERM

Spermosens AB (publ)

SPERM

• NGM: SPERM • Delayed

0.0116SEK 0%

0.0012 USD

As of 6 June 2026, Spermosens AB (publ) has a market cap of $3.93M USD, ranking #45321 globally and #748 in Sweden. It ranks #4015 in the Healthcare sector, and #846 in the Medical Devices industry.

Global Rank

45321

Country Rank

748

Sector Rank

4015

Industry Rank

846

Key Stats

Market Cap

$3.93MUSD

36.8M SEK

Enterprise Value

$3.16MUSD

29.96M SEK

EBITDA (TTM)

-$952.6KUSD

-9.02M SEK

Net Income (TTM)

-$981.54KUSD

-9.2M SEK

PB Ratio

1.1

Company Profile

Country (HQ)

Sweden

Sector

Healthcare

Industry

Medical Devices

CEO

Tore Duvold open_in_new

Employees

Founded

2018

Website

spermosens.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	21%	38%	87%	81%	100%	45%	-99%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
Nordic Growth Market (NGM) MIC: XNGM PRIMARY	SPERM ISIN: SE0015346424 Shares Out.: Shares Outstanding: 3.173B¹ TV: TradingView: NGM: SPERM SA: Stock Analysis: NGM: SPERM YF: Yahoo Finance: SPERM.ST GF: Google Finance: NGM: SPERM BA: Barron's: SPERM MS: Morningstar: XNGM: SPERM	0.0116 SEK	TV: TradingView: NGM: SPERM SA: Stock Analysis: NGM: SPERM YF: Yahoo Finance: SPERM.ST GF: Google Finance: NGM: SPERM BA: Barron's: SPERM MS: Morningstar: XNGM: SPERM

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Spermosens AB (publ)

Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)

Name	Market Cap (USD) diff.	PE	Country
Getinge AB (publ) STO: GETI-B	$5.59B 52.4B SEK 142K%	22.2	Sweden
S SciBase Holding AB STO: SCIB	$4.85B 45.5B SEK 124K%	-	Sweden
Elekta AB (publ) STO: EKTA-B	$2.23B 20.86B SEK 57K%	-	Sweden
Vitrolife AB (publ) STO: VITR	$1.59B 14.87B SEK 40K%	-	Sweden
Bonesupport Holding AB (publ) STO: BONEX	$1.53B 14.32B SEK 39K%	78.5	Sweden
Xvivo Perfusion AB (publ) STO: XVIVO	$907.38M 8.5B SEK 23K%	115.1	Sweden

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 4M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 4M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 4M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 3M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 3M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 3M%	22.2	Ireland

chevron_leftBack